New vaccine shows promise in fight against deadly brain cancer
Disease control
Not yet recruiting
This study tests a personalized vaccine (ZSNeo-DC1.1) made from a patient's own immune cells, combined with standard chemotherapy, for people with newly diagnosed glioblastoma. About 78 participants will be randomly assigned to receive the vaccine plus chemotherapy or chemotherap…
Phase: PHASE2 • Sponsor: ZSky Biotech Inc • Aim: Disease control
Last updated May 20, 2026 11:57 UTC